Status:
UNKNOWN
C-peptide Correlation With Microvascular Complications in T1DM
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Type 1 Diabetes
C-peptide
Eligibility:
All Genders
15-70 years
Brief Summary
The purpose of this study is to investigate the presence of residual insulin secretion in patients with DM1 and its correlation with the possible protection against early microvascular and macrovascul...
Detailed Description
The study will include approximately 200 patients, male and female, with DM1 who are being followed in the outpatient diabetic clinic of our hospital. Each patient will visit the Research Laboratory ...
Eligibility Criteria
Inclusion
- Type 1 diabetes
- Informed consent form
Exclusion
- Known macrovascular complications
- Known serious microvascular complications
Key Trial Info
Start Date :
March 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04474535
Start Date
March 3 2020
End Date
December 1 2021
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Clinical Research Laboratory, 1st Department of Propaedeutic Internal Medicine
Athens, Greece, 11527